YIH
RVMD icon

Y-Intercept (HK)’s Revolution Medicines RVMD Stock Holding History

Y-Intercept (HK)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-55,323
Closed -$2.58M – 1932
2025
Q3 		$2.58M Sell
55,323
-43,581
-44% -$1.71M 0.06% 472
2025
Q2 		$3.64M Buy
+98,904
New +$3.8M 0.09% 339
2024
Q4 		– Sell
-5,444
Closed -$247K – 1593
2024
Q3 		$247K Buy
+5,444
New +$237K 0.02% 1084
2024
Q2 		– Sell
-13,889
Closed -$448K – 1847
2024
Q1 		$448K Buy
+13,889
New +$412K 0.03% 769
2023
Q4 		– Sell
-31,065
Closed -$860K – 1594
2023
Q3 		$860K Buy
+31,065
New +$921K 0.08% 361

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Y-Intercept (HK)'s RVMD Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Revolution Medicines (RVMD) in Q4 2025, closing a stake of 55,323 shares — an estimated $2.58M sold.

Y-Intercept (HK) first reported a position in RVMD in Q3 2023 and held it in 5 quarters. The position peaked at $3.64M in Q2 2025. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • Y-Intercept (HK) reported no remaining Revolution Medicines position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 55,323 Revolution Medicines shares in Q4 2025, an estimated $2.58M.
  • Y-Intercept (HK) first reported a position in Revolution Medicines in Q3 2023 and held it in 5 quarters.
  • Y-Intercept (HK)'s Revolution Medicines position peaked at $3.64M in Q2 2025.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.